All news

Director Kathy Palmer Ordonez proposes selling 18,595 Pacific Biosciences (PACB) shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Pacific Biosciences of California (PACB) director Kathy Palmer Ordonez has filed a Form 144, proposing to sell 18,595 common shares with an approximate sale date of November 17, 2026, and an aggregate market value of $33,093.52. The shares were acquired through restricted stock vesting in February 2022 for services rendered.

Read original source

PACB company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.